Canadian Cancer Trials Group Bulletins

Trial Management Group

Trials Closed to Accrual

GAC.1 / CALGB 80101 -- Phase III Intergroup trial of adjuvant chemoradiation after resection of gastric or gastroesophageal adenocarcinoma -- was closed to accrual after achieving its target accrual on 29 May 2009.

IND.162 -- A phase I study of RAD001C in combination with temozolomide in patients with glioblastoma multiforme - was closed to accrual on 1 June 2009.